1274
Russ.Chem.Bull., Int.Ed., Vol. 58, No. 6, June, 2009
Shcherbakov et al.
monitored by TLC. After the reaction was complete, the solvent
was evaporated, a solid residue was crystallized from the
appropriate solvent.
C, 47.38; H, 2.65; F, 24.98; N, 9.21. IR, ν/cm–1: 3306 (NH);
1718 (O—C=O); 1648 (C=O); 1591, 1525 (NH, C=C); 1032
(CF). 1H NMR ((CD3)2CO), δ: 2.77, 2.87 (both s, 3 H each,
2 Me); 5.64, 14.79 (both br.s, 1 H each, NH). 19F NMR
((CD3)2CO), δ: –2.94, 2.33, 11.27, 18.31 (all m, 1 F each).
MS, m/z (Irel (%)): 304 [M] (14.56); 303 [M – H] (100); 284
[M – HF] (25.57).
6,7,8ꢀTrifluoroꢀ5ꢀhydroxyꢀ1,3ꢀdimethylbenzopyrano[2,3ꢀc]ꢀ
pyrazolꢀ4(1H)ꢀone (7). Compound 7 was obtained (71 mg, 50%)
by method B from coumarin 1 and methylhydrazine after reflux
in toluene for 72 h. Similarly, compound 7 was obtained from
coumarin 2 (72 mg, 51%) and by keeping benzopyrandione 6 in
ethanol (65 mg, 46%), a yellow powder, m.p. 137—139 °C (from
ethanol). Found (%): C, 50.47; H, 2.30; F, 19.75; N, 9.71.
C12H7F3N2O3. Calculated (%): C, 50.72; H, 2.48; F, 20.05;
N, 9.86. IR, ν/cm–1: 1641 (C=O); 1581, 1517 (C=C); 1001
(CF). 1H NMR ((CD3)2SO), δ: 2.47 (s, 3 H, Me); 3.85 (s, 3 H,
Me); 12.99 (s, 1 H, OH). 19F NMR ((CD3)2SO), δ: –5.58
(dd, 1 F, 4J = 5.3 Hz, 3J = 22.2 Hz); –2.46 (dd, 1 F, 4J = 5.3 Hz,
3J = 22.2 Hz); 13.38 (tm, 1 F, 3J = 22.2 Hz).
3ꢀAcetimidoylꢀ5,6,7,8ꢀtetrafluoroꢀ4ꢀhydroxycoumarin (1).
Compound 1 (110 mg, 80%) was obtained by method B from
benzopyrandione 3 after reflux in toluene for 72 h, a white
powder, m.p. 165 °C (data in Ref. 17: m.p. 171—173 °C).
5,6,7,8ꢀTetrafluoroꢀ3ꢀ[1ꢀ(2ꢀphenylhydrazino)ethylidene]ꢀ
benzopyranꢀ2,4ꢀdione (3). Compound 3 was obtained by method
A from acetimidoylcoumarin 1 and phenylhydrazine after stirring
at 20 °C for 24 h, the yield was 170 mg (93%) in Et2O, 114 mg
(62%) in MeCN, 64 mg (35%) in DMSO. Similarly, compound
3 was obtained from acetylcoumarin 2, the yield was 172 mg
(94%) in Et2O, 110 mg (60%) in EtOH, a yellow powder,
m.p. 221—224 °C (from diethyl ether). Found (%): C, 55.64;
H, 2.54; F, 20.87; N, 7.62. C17H10F4N2O3. Calculated (%):
C, 55.75; H, 2.75; F, 20.75; N, 7.65. IR, ν/cm–1: 3312 (NH);
1690 (O—C=O); 1650 (C=O); 1602, 1523 (NH, C=C); 1015
(CF). 1H NMR ((CD3)2CO), δ: 2.85 (s, 3 H, Me); 3.77 (s, 2 H,
2 NH); 7.18 (dm, 5 H, Ph). 19F NMR ((CD3)2CO), δ: –2.54,
2.55, 12.04, 18.96 (all m, 1 F each). MS, m/z (Irel (%)): 366 [M]
(14.06); 365 [M – H] (70.80); 274 [M – C6H5NH2] (23.23); 233
[C9HF4O3] (11.41); 216 [C9F4O2] (51.38).
Crystallographic data and parameters of Xꢀray structural
experiment for compound 7: C12H7F3N2O3, M = 284.20,
monoclinic crystal system, space group Р2(1)/n, a = 7.5687(9) Å,
b = 11.0239(14) Å, c = 13.0614(16) Å, α = 90.00°, β =
6,7,8ꢀTrifluoroꢀ5ꢀhydroxyꢀ3ꢀmethylꢀ1ꢀphenylbenzopyranoꢀ
[2,3ꢀc]pyrazolꢀ4(1H)ꢀone (4). Compound 4 was obtained
(130 mg, 75%) by method B from coumarin 1 and phenylꢀ
hydrazine after reflux in toluene for 72 h. Similarly, compound
4 was obtained (119 mg, 69%) from coumarin 2 and phenylꢀ
hydrazine. Compound 4 was also obtained (73 mg, 42%) by
heating benzopyrandione 3 in acetic acid in a water bath at
100 °C for 72 h and by heating pyrazolone 5 in acetic acid in a
water bath at 100 °C for 28 h (23 mg, 38%), a brown powder,
m.p. 215 °C (from ethanol). Found (%): C, 58.50; H, 2.63;
F, 16.55; N, 8.03. C17H9F3N2O3. Calculated (%): C, 58.97;
H, 2.62; F, 16.46; N, 8.09. IR, ν/cm–1: 1671, 1640 (C=O);
= 91.565(10)°, γ = 90.00°; V = 1089.4(2) Å3; Z = 4; dcalc
=
= 1.733 g cm–3, μ = 0.0159 mm–1, the total number of reflecꢀ
tions were 3469, the number of independent reflections were
1644, the Rꢀfactor was 0.0412, the number of refining parameters
were 197.
6,8ꢀDifluoroꢀ5ꢀhydroxyꢀ1,3ꢀdimethylꢀ7ꢀ(2ꢀmethylhydrazino)ꢀ
benzopyrano[2,3ꢀc]pyrazolꢀ4(1H)ꢀone (8). Compound 8 was
obtained (59 mg, 38%) by method A from coumarin 1 and
methylhydrazine upon stirring in DMSO at ~20 °C for 72 h, a
pale yellow powder, m.p. 185—190 °C (from ethanol). Found (%):
C, 50.04; H, 3.78; F, 12.01; N, 17.97. C13H12F2N4O3. Calcuꢀ
1
1623, 1596, 1541 (C=C); 1020 (CF). H NMR ((CD3)2SO), δ:
lated (%): C, 50.33; H, 3.90; F, 12.25; N, 18.06. IR, ν/cm–1
:
2.58 (s, 3 H, Me); 7.49—7.87 (m, 5 H, Ph); 12.80 (s, 1 H,
OH). 19F NMR ((CD3)2CO), δ: –5.36 (dd, 1 F, 4J = 4.9 Hz,
3J = 21.9 Hz); –1.93 (dd, 1 F, 4J = 4.9 Hz, 3J = 21.9 Hz); 13.79
(tm, 1 F, 3J = 21.9 Hz).
3354 (NH); 1660 (C=O); 1626, 1584 (NH, C=C); 1000 (CF).
1H NMR ((CD3)2SO), δ: 2.41, 3.79 (both s, 3 H each, 2 Me);
3.18 (m, 3 H, Me); 4.89 (br.s, 2 H, 2 NH); 12.54 (br.s, 1 H, OH).
19F NMR ((CD3)2SO), δ: 7.27, 10.32 (both br.s, 1 F each).
4ꢀ(2,3,4,5ꢀTetrafluoroꢀ6ꢀhydroxybenzoyl)ꢀ5ꢀmethylꢀ
2ꢀphenylꢀ1,2ꢀdihydroꢀ3Hꢀpyrazolꢀ3ꢀone (5). Compound 5 was
obtained (84 mg, 46%) by method A from coumarin 1 and
phenylhydrazine after stirring in ethanolic HCl (30 wt.%) at
~20 °C for 72 h, a brown powder, m.p. 198—205 °C (from
ethanol). Found (%): C, 58.33; H, 2.82; F, 20.92; N, 7.49.
C17H10F4N2O3. Calculated (%): C, 55.75; H, 2.75; F, 20.75;
N, 7.65. IR, ν/cm–1: 3062 (OH); 1691, 1655 (C=O); 1596, 1520
This work was financially supported by the Russian
Foundation for Basic Research (Project No. 09ꢀ03ꢀ002742)
and Council on Grants of the President of the Russian
Federation (Program for the State Support of Leading
Scientific Schools, Grant NSh 3758.2008.3).
1
References
(C=C); 992 (CF). H NMR ((CD3)2SO), δ: 2.31 (s, 3 H, Me);
6.43 (s, 1 H, NH); 7.22—7.39 (m, 5 H, Ph); 10.95 (s, 1 H,
OH). 19F NMR ((CD3)2CO), δ: –8.14, 1.94, 6.49, 21.80 (all m,
1 F each).
1. G. A. Kuznetsova, Prirodnye kumariny i furokumariny
[Natural Coumarins and Furocoumarins], Nauka, Leningrad,
1967 (in Russian).
2. M. D. Mashkovskii, Lekarstvennye sredstva [Medicines],
14th ed., Novaya Volna Publ. Ltd., Moscow, 2002, vol. 1,
540 pp.; vol. 2, 608 pp. (in Russian).
3. V. I. Saloutin, Z. E. Skryabina, I. T. Bazil´, S. P. Kisil´,
J. Fluor. Chem., 1999, 94, 83.
4. K. V. Shcherbakov, Y. V. Burgart, V. I. Saloutin, O. N.
Chupakhin, Heterocycles, 2006, 69, 319.
5,6,7,8ꢀTetrafluoroꢀ3ꢀ[1ꢀ(2ꢀmethylhydrazino)ethylidene]ꢀ
benzopyranꢀ2,4ꢀdione (6). Compound 6 was obtained by method
A from coumarin 1 and methylhydrazine upon stirring at ~20 °C
for 24 h, the yield was 134 mg (88%) in Et2O, 120 mg (79%)
in MeCN. Similarly, compound 6 was obtained from coumarin
2 in diethyl ether (137 mg, 90%), a pale yellow powder,
m.p. 164—166 °C (from diethyl ether). Found (%): C, 47.12;
H, 2.45; F, 24.67; N, 9.11. C12H8F4N2O3. Calculated (%):